Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden
· Delayed Price · Currency is SEK 5.90
-0.09 (-1.50%)
At close: Mar 9, 2026
-68.83% (1Y)
| Market Cap | 121.55M |
| Revenue (ttm) | 152.35M |
| Net Income (ttm) | 127.24M |
| Shares Out | 20.61M |
| EPS (ttm) | 10.45 |
| PE Ratio | 0.96 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 68,456 |
| Average Volume | 69,099 |
| Open | 5.89 |
| Previous Close | 5.99 |
| Day's Range | 5.65 - 6.20 |
| 52-Week Range | 5.62 - 38.25 |
| Beta | 0.66 |
| RSI | 25.10 |
| Earnings Date | Feb 20, 2026 |